ArticlePloS one2025
Evaluation of anti-ulcer activity of hydromethanol crude extract and solvent fractions of Vicia faba (Fabaceae) seeds in mice.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peptic ulcer disease affects 10% of the global population, and current treatments have limitations. Vicia faba seeds are traditionally used in Ethiopia for gastric ulcers and gastritis, but scientific evidence is lacking. Seeds were extracted with 80% hydro-methanol to evaluate its antiulcer effect, and part of the extract was fractionated into n-hexane, ethyl acetate, and aqueous solvents. The antiulcer activity of the crude extract and solvent fractions was tested using pylorus ligation and ethanol-induced ulcer models. Repeated dose studies were also performed on both models. In a pylorus ligation-induced ulcer model, single-dose studies showed that 200 mg/kg significantly reduced ulcer number, score (P < 0.05), and index (P < 0.01), providing 39.83% protection. The 400 mg/kg, significantly reduced ulcer number, and score (P < 0.01), providing 55.80% protection. In a repeated-dose study, 100 mg/kg significantly reduced ulcer number and score (P < 0.05). The 200 mg/kg dose showed stronger effects (P < 0.01, for the above parameters, respectively). The highest dose (400 mg/kg) significantly reduced ulcer parameters (P < 0.001) and also lowered gastric juice volume (P < 0.01), acidity (P < 0.05), and raised pH (P < 0.01), providing 59.17% protection. In the ethanol-induced ulcer model, single-dose crude extract provided an ulcer index protection of 23.39%, 34.90%, and 54.04% at 100, 200, and 400 mg/kg, respectively. Repeated administration of the crude extract increased ulcer protection to 34.94%, 50.91%, and 65.72% at the same respective doses. All doses of the aqueous and the ethyl acetate fractions also showed antiulcer activity. This study confirmed that Vicia faba seeds crude extract and solvent fractions have significant antiulcer activity, providing scientific evidence supporting the traditional use of V. faba seeds as a remedy for gastric ulcers in Ethiopia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.